Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 6
2014 35
2015 210
2016 311
2017 280
2018 276
2019 260
2020 243
2021 196
2022 177
2023 164
2024 80

Text availability

Article attribute

Article type

Publication date

Search Results

1,903 results

Results by year

Filters applied: . Clear all
Page 1
The argument for using imatinib in CML.
Claudiani S, Apperley JF. Claudiani S, et al. Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):161-167. doi: 10.1182/asheducation-2018.1.161. Hematology Am Soc Hematol Educ Program. 2018. PMID: 30504305 Free PMC article. Review.
Imatinib Mesylate.
Waller CF. Waller CF. Recent Results Cancer Res. 2018;212:1-27. doi: 10.1007/978-3-319-91439-8_1. Recent Results Cancer Res. 2018. PMID: 30069623
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial.
Brümmendorf TH, Cortes JE, Milojkovic D, Gambacorti-Passerini C, Clark RE, le Coutre P, Garcia-Gutierrez V, Chuah C, Kota V, Lipton JH, Rousselot P, Mauro MJ, Hochhaus A, Hurtado Monroy R, Leip E, Purcell S, Yver A, Viqueira A, Deininger MW; BFORE study investigators. Brümmendorf TH, et al. Leukemia. 2022 Jul;36(7):1825-1833. doi: 10.1038/s41375-022-01589-y. Epub 2022 May 28. Leukemia. 2022. PMID: 35643868 Free PMC article. Clinical Trial.
Imatinib-induced generalized vitiligo.
Jain A. Jain A. Br J Haematol. 2022 Jun;197(5):511. doi: 10.1111/bjh.18096. Epub 2022 Mar 14. Br J Haematol. 2022. PMID: 35285938 No abstract available.
Imatinib mesylate-induced acute hepatotoxicity.
Frikha I, Fakhfakh Y, Sahnoun R, Chtourou L, Medhaffar M, Elloumi M. Frikha I, et al. J Oncol Pharm Pract. 2023 Dec;29(8):2027-2030. doi: 10.1177/10781552231188307. Epub 2023 Jul 18. J Oncol Pharm Pract. 2023. PMID: 37464887
Imatinib attenuates reperfusion injury in a rat model of acute myocardial infarction.
Konijnenberg LSF, Luiken TTJ, Veltien A, Uthman L, Kuster CTA, Rodwell L, de Waard GA, Kea-Te Lindert M, Akiva A, Thijssen DHJ, Nijveldt R, van Royen N. Konijnenberg LSF, et al. Basic Res Cardiol. 2023 Jan 13;118(1):2. doi: 10.1007/s00395-022-00974-z. Basic Res Cardiol. 2023. PMID: 36639597 Free PMC article.
1,903 results